"Companies must carefully navigate the legal framework applicable to patents while complying with regulatory demands."
In an interview to "The Clinical Trials Vanguard", Joana Piriquito Santos, partner at NLP, explores the challenges and key priorities for biotech and pharma start-ups in managing intellectual property during clinical trials.
When asked about what would be the top 3 recommendations for IP protection, the NLP partner mentioned: “First, have a solid patent strategy. Second, during clinical trials, be aware of the information that is becoming publicly available. (…) Third, you need to take a holistic approach, considering the complex legal framework for pharmaceutical companies. It’s all about teamwork. Everyone needs to understand the business model and the market, and there must be cooperation between those working on the business side, on research, on data protection matters, clinical trials, and IP.”
